News
Your friends might be your underrated health supplement highlights how connection affects immunity, stress, sleep, and ...
5d
News-Medical.Net on MSNHow microRNA is transforming science: From discovery to diagnosticsIn this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and ...
Companion Diagnostics Market is Segmented by Type (Immunohistochemistry, Molecular Diagnosis), by Application (Oncology, Cardiovascular, Central ...
How alcohol affects women differently than men from metabolism and liver damage to cancer risk mental health and hormonal ...
A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical ...
CTC are outnumbered by red blood cells and leukocytes in the blood ... these clinical samples is often required to obtain pure tumor populations that will allow accurate detection, measurement ...
This new study is one of the first to look at whether metformin could actually fight colon cancer cells once the disease develops. Based on what Loomans-Kropp and her team have seen so far in cell ...
which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new ... May 7, 2025 — A phase I study of a next ...
the ongoing study focuses on how metformin interacts with colon cancer cells that are particularly difficult to treat. Early lab tests suggest that metformin has the potential to slow the growth ...
Ampli1™ LowPass Kit applications include the characterization and investigation of genomic heterogeneity and evolution in tumor cell populations such as individual circulating tumor cells (CTCs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results